European Approval for Eye Care Drug Jetrea

The European Commission has approved the drug, Jetrea, manufactured by ThromboGenics. The eye care division of Novartis, Alcon would soon market the drug in Europe.

Pharmaceutical company, ThromboGenics, has received the green signal from the European Commission for its drug, Jetrea (ocriplasmin).

Jetrea is used in treating vitreomacular traction (VMT), an age related disorder in the eye. VMT causes holes in the macula, an important area in the retina responsible for vision.

Age Related Macular Degeneration (AMD) - Causes, Symptoms, Diagnosis, Treatment & Prevention
Age related macular degeneration is a disease of the elderly, wherein the macula or the central part of the retina gets affected, leading to loss of vision.

It is estimated that 250,000-300,000 patients in Europe alone suffer from this condition and surgery at an advanced stage is the major treatment option available currently. However, a single injection of Jetrea, the need for surgery could be avoided in many cases.

ThromboGenics holds the rights to market the drug in USA while its partner, Novartis would market the drug in Europe through its eye care division, Alcon.

Source-Medindia

Foods that Give You Sparkling Eyes
Food not only sustains us but the kind and quality of food determines the state of your health, which includes your eyes. Let us see which foods can bring a sparkle to your eyes!

Aspirin Use Ups Risk of Age-related Macular Degeneration
Regular use of aspirin is associated with a higher risk of neovascular age-related macular degeneration (AMD), finds study published in JAMA Internal Medicine.

Compound Found in Herb Rosemary Promotes Eye Health, Protects Against Macular Degeneration
Western medicine in recent years has shown renewed interest in herbs widely used in Asian and early European cultures. The herb rosemary is now attracting attention because it promotes eye health.